Exact Sciences Revenue 2024

The Exact Sciences Revenue history

YEAR	REVENUE (undefined USD)	GROSS MARGIN (%)
2029e	4.92	37,51
2028e	4.51	40,92
2027e	4.08	45,27
2026e	3.69	50,00
2025e	3.28	56,20
2024e	2.89	63,93
2023	2.5	73,83
2022	2.08	72,44
2021	1.77	74,04
2020	1.49	76,24
2019	0.88	75,27
2018	0.45	74,32
2017	0.27	70,56
2016	0.1	54,53
2015	0.04	37,82
2014	0	-138,89
2013	0	100,00
2012	0	100,00
2011	0	97,62
2010	0.01	100,00
2009	0	97,92
2008	-0	100,00
2007	0	94,44
2006	0	81,25
2005	0	86,05
2004	0	89,80

Exact Sciences Aktienanalyse

What does Exact Sciences do?

Exact Sciences Corp is a US-based company specializing in the development, manufacturing, and marketing of diagnostics. It was founded in 1995 by Kevin T. Conroy and is headquartered in Madison, Wisconsin. The company's main focus is on cancer diagnostics. It has developed an innovative test called the Cologuard test, which is a simple, non-invasive method for detecting colorectal cancer. The test can provide accurate results by analyzing a stool sample from the patient. The Cologuard test is FDA approved and recommended by physicians in the US. Exact Sciences has also developed an extensive portfolio of liquid biopsy tests, which can help detect cancer in its early stages by identifying changes in the patient's blood. The company aims to expand its position in the market for non-invasive cancer diagnostics. Originally founded as an oncology diagnostics company specializing in the development of tests for early tumor detection, Exact Sciences expanded its focus to colorectal cancer diagnostics in 2009 after acquiring the rights to a patented biomarker. The company has experienced rapid growth in recent years and has become a leader in the field of non-invasive cancer diagnostics. It has made several acquisitions, including the acquisition of Genomic Health, a provider of cancer diagnostics and molecular tests. Exact Sciences is divided into two business segments: 1. Diagnostics Exact Sciences develops and distributes diagnostics for the detection of various forms of cancer. The company has a range of products on the market, including: - Cologuard: A test for detecting colorectal cancer - Oncotype DX: A test for detecting various types of breast cancer - Oncotype MAP: A test for detecting colorectal and gastric cancer - Oncotype IQ: A platform for detecting various types of cancer 2. Research and Development Exact Sciences also conducts research and development in the field of cancer diagnostics. The company is working on developing tests for detecting many types of cancer in their early stages. It has also formed partnerships with other companies and organizations to support its research in this field. In conclusion, Exact Sciences Corp is an innovative company specializing in the development of diagnostics for the detection of various types of cancer. The company has achieved a strong market position in non-invasive cancer diagnostics and aims to further expand its product range. With the Cologuard test and its other diagnostics, the company has saved many lives and will continue to contribute to the early detection and treatment of cancer in the future. Exact Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Exact Sciences's Sales Figures

The sales figures of Exact Sciences originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Exact Sciences’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Exact Sciences's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Exact Sciences’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Exact Sciences Stock

How much revenue did Exact Sciences generate this year?

Exact Sciences has achieved a revenue of 2.89 B USD this year.

How much was the turnover of the company Exact Sciences compared to the previous year?

The revenue of Exact Sciences has increased by 15.49% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Exact Sciences?

The revenue of Exact Sciences is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Exact Sciences measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Exact Sciences so important for investors?

The revenue of Exact Sciences is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Exact Sciences pay?

Over the past 12 months, Exact Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Exact Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Exact Sciences?

The current dividend yield of Exact Sciences is .

When does Exact Sciences pay dividends?

Exact Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Exact Sciences?

Exact Sciences paid dividends every year for the past 0 years.

What is the dividend of Exact Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Exact Sciences located?

Exact Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Exact Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Exact Sciences from 6/5/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/5/2024.

When did Exact Sciences pay the last dividend?

The last dividend was paid out on 6/5/2024.

What was the dividend of Exact Sciences in the year 2023?

In the year 2023, Exact Sciences distributed 0 USD as dividends.

In which currency does Exact Sciences pay out the dividend?

The dividends of Exact Sciences are distributed in USD.